Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
Abstract
Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The MS may increase cardiovascular event risk through prothrombotic or inflammatory mechanisms rather than by accelerating atherosclerotic progression.
“Whereas the MS may play a limited role in accelerating atherosclerotic progression, it may significantly increase the risk of vascular events through prothrombotic or inflammatory mechanisms.29 -31”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [31]
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950 · see citing works
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239 · see citing works
(1989) · PubMed · Cited by 3,139 · see citing works
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,171 · see citing works
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937 · see citing works
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645 · see citing works
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387 · see citing works
Siedel, J., Hägele, E., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942 · see citing works
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915 · see citing works
Fibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 594 · see citing works
Kannel, W. B., D’Agostino, R. B., & Belanger, A. J. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90063-9 · Cited by 466 · see citing works
Meade, T. W., Imeson, J., & Stirling, Y. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92556-6 · Cited by 432 · see citing works
Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial Infarction
Chalmers, T. C., Matta, R. J., Smith, H., & Kunzler, A.-M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711172972004 · Cited by 423 · see citing works
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.
Meade, T. W., Chakrabarti, R., Haines, A., North, W. R. S., & Stirling, Y. (1979) · BMJ · doi:10.1136/bmj.1.6157.153 · Cited by 410 · see citing works
Plasma fibrinogen--a major coronary risk factor.
Stone, M. C., & Thorp, J. M. (1985) · PubMed · Cited by 358 · see citing works
Balleisen, L., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657877 · Cited by 345 · see citing works
Nägele, U., Hägele, E., Sauer, G., Wiedemann, E., Lehmann, P., Wahlefeld, A. W., & Gruber, W. (1984) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1984.22.2.165 · Cited by 313 · see citing works
OOLOFESSON, B. O., Dahlén, G., & Nilsson, T. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059384 · Cited by 225 · see citing works
Miller, G. J., Martin, J., Webster, J., Wilkes, H., Miller, N. E., Wilkinson, W. H., & Meade, T. W. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90174-7 · Cited by 217 · see citing works
Blood rheology in arterial disease
Lowe, G. D. O. (1986) · Clinical Science · doi:10.1042/cs0710137 · Cited by 214 · see citing works
Fibrinogen: a possible link between social class and coronary heart disease.
Markowe, H. L. J., Marmot, M. G., Shipley, M. J., Bulpitt, C., Meade, T. W., Stirling, Y., Vickers, M. V., & Semmence, A. (1985) · BMJ · doi:10.1136/bmj.291.6505.1312 · Cited by 205 · see citing works
Plasma fibrinogen and coronary risk factors: The Scottish heart health study
Lee, A. J., Smith, W. C. S., Lowe, G. D. O., & Tunstall-Pedoe, H. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90075-z · Cited by 200 · see citing works
Papp, A. C., Hatzakis, H., Bracey, A., & Wu, K. K. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646519 · Cited by 182 · see citing works
Self-citation4 Fibrinogen, Fibrin and Fibrin Degradation Products in Relation to Atherosclerosis
Smith, E. B. (1986) · Clinics in Haematology · doi:10.1016/s0308-2261(18)30021-3 · Cited by 163 · see citing works
Measuring plasma fibrinogen to predict stroke and myocardial infarction.
Minno, G. D., & Mancini, M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.1.1 · Cited by 162 · see citing works
Physical Conditioning Augments the Fibrinolytic Response to Venous Occlusion in Healthy Adults
Williams, R. S., Logue, E. E., Lewis, J. L., Barton, T., Stead, N. W., Wallace, A. G., & Pizzo, S. V. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021802 · Cited by 151 · see citing works
Rosengren, A., Wilhelmsen, L., Welin, L., Tsipogianni, A., Teger‐Nilsson, A. ‐., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.300.6725.634 · Cited by 148 · see citing works
Plasma fibrinogen and ischemic heart disease risk factors.
Møller, L., & Kristensen, T. S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.344 · Cited by 131 · see citing works
Mitropoulos, K. A., Miller, G. J., Reeves, B. E. A., Wilkes, H., & Cruickshank, J. K. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90104-4 · Cited by 119 · see citing works
Ritchie, D. G., Levy, B., Adams, M. A., & Fuller, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1530 · Cited by 118 · see citing works
Stamler, J., Berkson, D. M., Lindberg, H. A., Hall, Y., Miller, W. A., Mojonnier, L., Levinson, M. J., Cohen, D. B., & Young, Q. D. (1966) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33232-1 · Cited by 118 · see citing works
Increased Neutrophil Elastase Activity in Cigarette Smokers
Weitz, J. I., CROWLEY, K. A., LANDMAN, S. L., LIPMAN, B. I., & YU, J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-680 · Cited by 114 · see citing works
Balleisen, L., Assmann, G., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1660106 · Cited by 114 · see citing works
YARNELL, J. W. G., Sweetnam, P. M., Rogers, S., Elwood, P. C., Bainton, D., Baker, I. A., Eastham, R. D., O’Brien, J. R., & Etherington, M. D. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.8.909 · Cited by 113 · see citing works
The effect of physiological levels of fibrinogen on platelet aggregation
Meade, T. W., Vickers, M. V., Thompson, S. G., & Seghatchian, M. J. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90185-9 · Cited by 104 · see citing works
Short-term intraindividual variability in hemostasis factors the ARIC study
Chambless, L. E., McMahon, R. P., Wu, K. K., Folsom, A. R., Finch, A., & Shen, Y.-L. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90017-k · Cited by 99 · see citing works
Self-citationBaker, I. A., Eastham, R. D., Elwood, P. C., Etherington, M. D., O'Brien, J. R., & Sweetnam, P. M. (1982) · Heart · doi:10.1136/hrt.47.5.490 · Cited by 79 · see citing works
Relationship between sex hormones and haemostatic factors in healthy middle-aged men
Bonithon‐Kopp, C., Scarabin, P., Bara, L., Castanier, M., Jacqueson, A., & Roger, M. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90303-6 · Cited by 76 · see citing works
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
Skartlien, A. H., Lyberg-Beckmann, S., Holme, I., Hjermann, I., & Prydz, H. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.798 · Cited by 75 · see citing works
Blood Coagulation and Fibrinolysis in a Random Sample of 788 Men 54 Years Old
Korsan-Bengtsen, K., Wilhelmsen, L., & Tibblin, G. (1972) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649045 · Cited by 64 · see citing works
Conjugated equine oestrogens and blood clotting: a follow-up report.
Poller, L., THOMSON, J. M., & Coope, J. (1977) · BMJ · doi:10.1136/bmj.1.6066.935 · Cited by 59 · see citing works
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90176-8 · Cited by 56 · see citing works
Acute changes in Atherogenic and Thrombogenic Factors with Cessation of Smoking
Feher, M. D., RAMPLING, M. W., Brown, J., Robinson, R., Richmond, W., Cholerton, S., Bain, B. J., & Sever, P. S. (1990) · Journal of the Royal Society of Medicine · doi:10.1177/014107689008300306 · Cited by 51 · see citing works
Factor VII activation and menopausal status
Scarabin, P., Bonithon‐Kopp, C., Bara, L., Malméjac, A., Guize, L., & Samama, M. M. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90322-4 · Cited by 50 · see citing works
The contribution of leukocyte proteases to fibrinolysis
Plow, E. F. (1986) · Annals of Hematology · doi:10.1007/bf00320577 · Cited by 41 · see citing works
Wilkes, H., Kelleher, C. C., & Meade, T. W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90398-4 · Cited by 40 · see citing works
Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.
Yarnell, J. W. G., FEHILY, A. M., Milbank, J., Kubicki, A. J., Eastham, R. D., & Hayes, T. M. (1983) · Journal of Epidemiology & Community Health · doi:10.1136/jech.37.2.137 · Cited by 38 · see citing works
Gurewich, V., Lipiński, B., & Hyde, E. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648080 · Cited by 37 · see citing works
Miller, G. J., Seghatchian, M. J., Walter, S. J., Howarth, D., Thompson, S. G., ESNOUF, M. P., & Meade, T. W. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb02941.x · Cited by 34 · see citing works
Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
Mann, K. G. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.783 · Cited by 28 · see citing works
Effect of weight loss on coagulation factors VII and X
Baron, J. A., Mann, J. I., & Stukel, T. A. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90432-3 · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J. (1999) · BMJ · doi:10.1136/bmj.319.7224.1523 · Cited by 1,360 · see citing works
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805 · see citing works
Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 730 · see citing works
Self-citationPlasma proteomic signature of age in healthy humans
Tanaka, T., Biancotto, A., Moaddel, R., Moore, A. Z., Gonzalez‐Freire, M., Aon, M. A., Candia, J., Zhang, P., Cheung, F., Fantoni, G., et al. (2018) · Aging Cell · doi:10.1111/acel.12799 · Cited by 562 · see citing works
Woodhouse, P. R., Khaw, K., Plummer, M., Meade, T. W., & Foley, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92689-1 · Cited by 553 · see citing works
Morrissey, J. H., Macik, B., Neuenschwander, P., & Comp, P. (1993) · Blood · doi:10.1182/blood.v81.3.734.734 · Cited by 511 · see citing works
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487 · see citing works
Diabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443 · see citing works
von Känel, R., Mills, P. J., Fainman, C., & Dimsdale, J. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00003 · Cited by 422 · see citing works
“There is substantial evidence that socioeconomic status is inversely related to plasma fibrinogen (84, 101, 103, 105, 108, 109, 113–122) and FVII levels (101, 114, 117, 121).”
BackgroundSmith, N. L., Chen, M., Dehghan, A., Strachan, D. P., Basu, S., Soranzo, N., Hayward, C., Rudan, I., Sabater‐Lleal, M., Bis, J. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.869156 · Cited by 369 · see citing works
Self-citationScarabin, P., Alhenc‐Gelas, M., Plu‐Bureau, G., Taisne, P., Agher, R., & Aiach, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3071 · Cited by 346 · see citing works
Cardiac rehabilitation past, present and future: an overview.
Mampuya, W. M. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.01.02 · Cited by 316 · see citing works
“Possible explanations for moderate alcohol consumption benefits include: HDL increase by stimulating the hepatic production of apo A-I and A-II, fibrinogen levels reduction, fibrinolysis stimulation, inflammation reduction and inhibition of platelet activation (61-65).”
BackgroundPeter, R., Alfredsson, L. S., Hammar, N., Siegrist, J., Theorell, T., & Westerholm, P. J. M. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.9.540 · Cited by 269 · see citing works
Fibrinogen: biochemistry, epidemiology and determinants
Kamath, S., & Lip, G. Y. H. (2003) · QJM · doi:10.1093/qjmed/hcg129 · Cited by 261 · see citing works
Brunner, E. J., Marmot, M. G., Canner, R., Beksinska, M., Smith, G. D., & O'Brien, J. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90147-6 · Cited by 260 · see citing works
Bostom, A. G., GAGNON, D. R., Cupples, L. A., Wilson, P. W. F., Jenner, J. L., Ordovás, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 254 · see citing works
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
Melnick, S. L., Shahar, E., Folsom, A. R., Grayston, J. T., Sorlie, P. D., Wang, S.-P., & Szklo, M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90332-j · Cited by 246 · see citing works
Self-citationMcCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0684 · Cited by 234 · see citing works
Review article: Coagulation and fibrinolysis in diabetes
Alzahrani, S. H., & Ajjan, R. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110383723 · Cited by 231 · see citing works
“An association between fibrinogen levels, insulin and low high-density lipoprotein has been documented, indicating this protein is part of the cardiovascular risk cluster in diabetes.(21,37,38) High fibrinogen levels have been shown to predict progression of coronary artery calcification in T1DM,(39) and levels of thi…”
Background(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227 · see citing works
“Ethnicity, socioeconomic status, and season Adjusted mean fibrinogen levels were approximately 0.12 g/liter higher in Blacks than in Whites (35).”
BackgroundInfluentialFolsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 224 · see citing works
Self-citationSara, J. D. S., Prasad, M., Eleid, M. F., Zhang, M., Widmer, R. J., & Lerman, A. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008073 · Cited by 226 · see citing works
Folsom, A. R., Wu, K. K., Shahar, E., & DAVIS, C. E. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1829 · Cited by 186 · see citing works
Self-citationVirchow’s Triad Revisited: Blood Constituents
Chung, I. K.-K., & Lip, G. Y. H. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083844 · Cited by 161 · see citing works
The role of estrogen in cardiovascular disease
Baker, L., Meldrum, K. K., Wang, M., Sankula, R., Vanam, R. P., Raiesdana, A., Tsai, B. M., Hile, K. L., Brown, J. W., & Meldrum, D. R. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00215-4 · Cited by 161 · see citing works
Statin Therapy in Acute Coronary Syndromes
Sposito, A. C., & Chapman, M. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000032033.39301.6a · Cited by 159 · see citing works
Helicobacter pylori Seropositivity and Coronary Heart Disease Incidence
Folsom, A. R., Nieto, F. J., Sorlie, P. D., Chambless, L. E., & Graham, D. Y. (1998) · Circulation · doi:10.1161/01.cir.98.9.845 · Cited by 159 · see citing works
Self-citationWoodward, M., Lowe, G. D. O., Rumley, A., Tunstall‐Pedoe, H., Philippou, H., Lane, D. A., & Morrison, C. E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1232935.x · Cited by 155 · see citing works
Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study
Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.649 · Cited by 151 · see citing works
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149 · see citing works
Stensvold, I., Tverdal, A., Urdal, P., & Graff‐Iversen, S. (1993) · BMJ · doi:10.1136/bmj.307.6915.1318 · Cited by 142 · see citing works
Juhan-Vague, I., Alessi, M., & Vague, P. (1996) · Annals of Medicine · doi:10.3109/07853899608999095 · Cited by 142 · see citing works
Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men
CIGOLINI, M., Targher, G., Andreis, I. A. B., Tonoli, M., Agostino, G., & Sandre, G. D. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.368 · Cited by 141 · see citing works
Eliasson, M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05425-i · Cited by 140 · see citing works
Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T. B., & Cohen, H. J. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.11.m649 · Cited by 138 · see citing works
Plasma albumin and platelet function: relevance to atherogenesis and thrombosis
Mikhailidis, D. P., & Ganotakis, E. S. (1996) · Platelets · doi:10.3109/09537109609023571 · Cited by 129 · see citing works
Characteristics of Anticoagulant Therapy and Comorbidity Related to Overanticoagulation
Beest, F. P.-V., van Meegen, E., Rosendaal, F. R., & Stricker, B. H. C. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616088 · Cited by 127 · see citing works
“These factors may also affect the response to oral anticoagulants (19-24) and were thus considered as potential confounders.”
BackgroundWamala, S. P., Mittleman, M. A., Schenck-Gustafsson, K., & Orth-Gomér, K. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.3.315 · Cited by 127 · see citing works
Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic View
Folsom, A. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616234 · Cited by 126 · see citing works
Self-citationSEARCHING FOR THE BIOLOGICAL PATHWAYS BETWEEN STRESS AND HEALTH
Kelly, S., Hertzman, C., & Daniel, M. (1997) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.18.1.437 · Cited by 123 · see citing works
Sanders, T. A. B., Oakley, F. R., Miller, G. J., Mitropoulos, K. A., Crook, D., & Oliver, M. F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3449 · Cited by 122 · see citing works
Scarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123 · see citing works
Functional Characterization of the Human Factor VII 5′-Flanking Region
Pollak, E. S., Hung, H.-L., Godin, W., Overton, G. C., & High, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1738 · Cited by 123 · see citing works
Hormone Replacement Therapy and the Cardiovascular System
Stevenson, J. C., Crook, D., Godsland, I. F., Collins, P., & Whitehead, M. I. (1994) · Drugs · doi:10.2165/00003495-199400472-00007 · Cited by 117 · see citing works
“1990) and fibrinogen (Folsom et al. 1991), and the antifibrinolytic factor, plasminogen activator inhibitor-I (Heinrich et al.”
BackgroundGreen, F. R., Hamsten, A., Blombäck, M., & Humphries, S. E. (1993) · PubMed · Cited by 113 · see citing works
Shahar, E., Folsom, A. R., Wu, K. K., Dennis, B. H., Shimakawa, T., Conlan, M. G., DAVIS, C. E., & Williams, O. D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1205 · Cited by 115 · see citing works
Self-citationHumphries, S. E., Ye, S., Talmud, P. J., Bara, L., Wilhelmsen, L., & Tiret, L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.96 · Cited by 108 · see citing works
Coagulation and atherothrombotic disease
Ajjan, R., & Grant, P. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.042 · Cited by 106 · see citing works
Trends in coronary artery disease and associated risk factors in sub-Saharan Africans
Akinboboye, O., Idris, O., Akinboboye, O., & Akinkugbe, O. O. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001562 · Cited by 104 · see citing works
Stensland-Bugge, E., Bønaa, K. H., & Joakimsen, O. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00486-x · Cited by 101 · see citing works
“Smoking is the most important lifestyle determinant of fibrinogen [20].”
BackgroundMansfield, M. W., Heywood, D. M., & Grant, P. J. (1996) · Circulation · doi:10.1161/01.cir.94.9.2171 · Cited by 102 · see citing works
Fibrinogen and Cardiovascular Risk
Ernst, E., & Köenig, W. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200207 · Cited by 99 · see citing works
Activation of the Coagulant Pathway in Cigarette Smokers
Bauer, K. A., Cooper, J. A., ROSENBERG, R. D., & Miller, G. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614942 · Cited by 97 · see citing works
“Neither of these possibilities, however, would appear to explain the reduction in VIIc observed in cigarette smokers in some studies (18, 42, 43).”
BackgroundInfluentialUpdate on cardiovascular disease in post-menopausal women
Gorodeski, G. I. (2002) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2002.0282 · Cited by 96 · see citing works
Eliasson, M., Evrin, P., & Lundblad, D. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90298-4 · Cited by 96 · see citing works
Venous thromboembolism and ethnicity
Roberts, L. N., Patel, R., & Arya, R. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07786.x · Cited by 94 · see citing works
“This contrasts with previous studies in which African-Americans were found to have significantly higher fibrinogen levels (by 0Æ1–0Æ6 g/l) compared to US whites (Folsom et al, 1991; Folsom et al, 1993).”
ResultInsulin resistance syndrome: interaction with coagulation and fibrinolysis
Köhler, H.-P. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09856 · Cited by 94 · see citing works
Kunutsor, S. K., Mäkikallio, T. H., Seidu, S., de Araújo, C. G. S., Dey, R. S., Blom, A. W., & Laukkanen, J. A. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00579-2 · Cited by 96 · see citing works
Lakka, T. A., & Salonen, J. T. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90111-d · Cited by 93 · see citing works
Population Correlates of Coagulation Factor VII
Scarabin, P., Vissac, A., Kirzin, J.-M., Bourgeat, P., Amiral, J., Agher, R., & Guize, L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1170 · Cited by 91 · see citing works
Heit, J. A., Beckman, M. G., Bockenstedt, P. L., Grant, A. M., Key, N. S., Kulkarni, R., Manco‐Johnson, M. J., Moll, S., Ortel, T. L., & Philipp, C. S. (2010) · American Journal of Hematology · doi:10.1002/ajh.21735 · Cited by 86 · see citing works
“When compared with Whites, Blacks have higher levels of fibrinogen, [35,36,38] factor VIII, [37,38,44] von Willebrand factor [37,38,44], and plasma fibrin D-dimer [38,45,46], and lower levels of protein C [36].”
BackgroundResultLindqvist, P. G., Epstein, E., & Olsson, H. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07460.x · Cited by 86 · see citing works
“Plasma viscosity is determined largely by fibrinogen, and a negative relationship between fibrinogen and physical activity has been established (Folsom et al, 1991; Stratton et al, 1991).”
BackgroundInfluence of Fibrinogen on Cardiovascular Disease
Kannel, W. B. (1997) · Drugs · doi:10.2165/00003495-199700543-00006 · Cited by 86 · see citing works
Saloma, V., Rasi, V., Pekkanen, J., Jauhiainen, M., Vahtera, E. M., Pietinen, P., KORHONEN, H. J., Kuulasmaa, K., & Ehnholm, C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90034-r · Cited by 84 · see citing works
Physical inactivity and idiopathic pulmonary embolism in women: prospective study
Kabrhel, C., Varraso, R., Goldhaber, S. Z., Rimm, E. B., & Camargo, C. A. (2011) · BMJ · doi:10.1136/bmj.d3867 · Cited by 80 · see citing works
Conquer, J. A., Cheryk, L. A., Chan, E., Gentry, P. A., & Holub, B. J. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00106-1 · Cited by 80 · see citing works
“factor VII, are positively associated with increased Internationally, the Inuit are thought to consume incidence of coronary artery disease [24–27].”
BackgroundPlasma fibrinogen and its correlates in Japanese and US population samples.
Iso, H., Folsom, A. R., Sato, S., Wu, K. K., Shimamoto, T., KOIKE, K., Iida, M., & Komachi, Y. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.783 · Cited by 80 · see citing works
Self-citationSanders, T. A. B., de Grassi, T., Miller, G. J., & Morrissey, J. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00335-4 · Cited by 78 · see citing works
“FVIIc is positively associated with plasma triacylglycerol concentration [10] and habitual dietary fat intake [11].”
BackgroundFibrinogen Gene Promoter −455 A Allele as a Risk Factor for Lacunar Stroke
Martiskainen, M., Pohjasvaara, T., Mikkelsson, J., Mäntylä, R., Kunnas, T. A., Laippala, P., Ilveskoski, E., Kaste, M., Karhunen, P. J., & Erkinjuntti, T. (2003) · Stroke · doi:10.1161/01.str.0000060029.23872.55 · Cited by 79 · see citing works
Gender‐Specific Risk Factors for Peripheral Artery Disease in a Voluntary Screening Population
Hiramoto, J. S., Katz, R., Weisman, S. M., & Conte, M. S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000651 · Cited by 75 · see citing works
“Fibrinogen levels also differ by gender and race and have been reported to be higher in women than men and in blacks compared to whites.(68,69,73) Adiponectin is the most abundant circulating adipokine and has both antiatherogenic and -inflammatory effects.”
BackgroundRelations between hemostasis variables and cardiovascular risk factors in middle-aged adults
Folsom, A. R., Conlan, M. G., DAVIS, C. E., & Wu, K. K. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90098-b · Cited by 75 · see citing works
Self-citationMennen, L. I., Balkau, B., Vol, S., Cacès, E., & Eschwège, E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.887 · Cited by 75 · see citing works
Low serum thyrotropin is associated with high plasma fibrinogen
Dörr, M., Robinson, D. M., Wallaschofski, H., Schwahn, C., John, U., Felix, S. B., & Völzke, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1786 · Cited by 73 · see citing works
Asthma and Its Association with Cardiovascular Disease in the Elderly
Enright, P., Ward, B. J., Tracy, R. P., & Lasser, E. C. (1996) · Journal of Asthma · doi:10.3109/02770909609077762 · Cited by 72 · see citing works
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance
Catena, C., Zingaro, L., Casaccio, D., & Sechi, L. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00567-2 · Cited by 71 · see citing works
Meade, T. W. (1996) · BMJ · doi:10.1136/bmj.312.7029.473 · Cited by 71 · see citing works
Cook, D. G. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.8.799 · Cited by 70 · see citing works
“Moreover, in the United States where fibrinogen levels among US-born Blacks are reported to be similar to or higher than those in Whites (8, 9), CHD rates in Blacks are higher than those in Whites while stroke rates are four times higher than in Whites (21), a considerably higher relative risk than in the United Kingd…”
BackgroundResultKario, K., Miyata, T., Sakata, T., Matsuo, T., & Kato, H. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.265 · Cited by 70 · see citing works
“In adults, body mass index has been shown to have a positive correlation with plasma FVIIc level in a population study.(17)-(41) However, our previous study of subjects older than 60 years did not show any correlation between body mass index and either FVIIc or FVILAg levels.”
BackgroundBarazzoni, R., Zanetti, M., Davanzo, G., Kiwanuka, E., Carraro, P., Tiengo, A., & Tessari, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6779 · Cited by 68 · see citing works
“Based on the above observations it is therefore unlikely that these potential confounding factors (38, 39) contributed to the alterations of fibrinogen turnover reported in the current investigation.”
BackgroundResultDiabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic
King, R., & Grant, P. J. (2016) · Herz · doi:10.1007/s00059-016-4414-8 · Cited by 68 · see citing works
“This prediabetes phase is associated with many of the abnormalities frequently observed in T2DM, such as endothelial cell (EC) dysfunction [7, 8], elevated PAI-1 [9], fibrinogen[10], coagulation factorVII [11, 12], and inflammatory proteins [13, 14], with similarpatterns seen inhealthy firstdegree relatives of patient…”
BackgroundInteraction Between Alcohol and Exercise
Elsayed, M., Ali, N. S., & Ali, Z. E.-S. (2005) · Sports Medicine · doi:10.2165/00007256-200535030-00005 · Cited by 67 · see citing works
Oakley, F. R., Sanders, T. A. B., & Miller, G. J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1202 · Cited by 67 · see citing works
Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women
Wamala, S. P., Mittleman, M. A., Horsten, M., Eriksson, M., Schenck-Gustafsson, K. G., Hamsten, A., Silveira, A. M. V., & Orth‐Gomér, K. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.485 · Cited by 65 · see citing works
“#1.15 mmol/L 3.46 (0.17) 1.25 (0.09) 452 ( 23 ) 4.9 (0.3) 7.7 (1.4) .1.15 mmol/L 3.16 (0.03) 1.09 (0.02) 416 (6) 4.9 (0.1) 2.9 (1.2) P 0.03 0.06 0.07 0.84 0.005”
InfluentialPregnancy-induced hypertension and insulin resistance, evidence for a connection
Innes, K. E., & Wimsatt, J. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780401.x · Cited by 67 · see citing works
Beest, F. J. A. P., van Meegen, E., Rosendaal, F. R., & Stricker, B. H. C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115723 · Cited by 63 · see citing works
Greendale, G. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040090010 · Cited by 63 · see citing works
Association Between Hypercoagulability and Severe Obstructive Sleep Apnea
Hong, S., Yun, H.-C., Yoo, J. H., & Lee, S. H. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.1367 · Cited by 61 · see citing works
Hormone therapy and venous thromboembolism
Peverill, R. E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00079-9 · Cited by 60 · see citing works
Regular exercise reduces fibrinogen levels: a review of longitudinal studies.
Ernst, E. (1993) · British Journal of Sports Medicine · doi:10.1136/bjsm.27.3.175 · Cited by 60 · see citing works
Nontraditional Cardiovascular Risk Factors
Oparil, S., & Oberman, A. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40503-8 · Cited by 60 · see citing works
Heywood, D. M., Carter, A. M., Catto, A. J., Bamford, J., & Grant, P. J. (1997) · Stroke · doi:10.1161/01.str.28.4.816 · Cited by 60 · see citing works
Hemostatic Factors and Estrogen during the Menopausal Transition
Sowers, M. R., Matthews, K. A., Jannausch, M. L., Randolph, J. F., McConnell, D. S., Sutton-Tyrrell, K., Little, R. J. A., Lasley, B. L., & Pasternak, R. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0591 · Cited by 59 · see citing works
Insulin Resistance Syndrome and Fibrinolytic Activity: The Northern Sweden MONICA Study
Lindahl, B., Asplund, K., Eliasson, M., & Evrin, P. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.2.291 · Cited by 59 · see citing works
Köenig, W., & Ernst, E. (2000) · Coronary Artery Disease · doi:10.1097/00019501-200003000-00006 · Cited by 58 · see citing works
Lifestyle and diet as risk factors for overanticoagulation
Beest, F. J. A. P., Geleijnse, J. M., van Meegen, E., Vermeer, C., Rosendaal, F. R., & Stricker, B. H. C. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00485-1 · Cited by 57 · see citing works
“A negative association with factor VII has been reported for physical activity, smoking, and intake of alcohol [ 8 ,9].”
BackgroundWinkler, U. H. (1992) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(92)90004-2 · Cited by 56 · see citing works
MacAuley, D., McCrum, E. E., STOTT, G., Evans, A. E., McRoberts, B., Boreham, C. A., Sweeney, K., & Trinick, T. R. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.3.258 · Cited by 55 · see citing works
Effect of Strenuous Exercise on Fibrinogen and Fibrinolysis in Healthy Elderly Men and Women
Schuit, A. J., Schouten, E. G., Kluft, C., de Maat, M. P. M., Menheere, P. P. C. A., & Kok, F. J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657639 · Cited by 55 · see citing works
Lifestyle factors and coagulation activation markers: the Caerphilly Study
YARNELL, J. W. G., Sweetnam, P. M., Rumley, A., & Lowe, G. D. O. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200112000-00015 · Cited by 54 · see citing works
“Factor VIIc showed a trend with body mass index as reported elsewhere [6,18]; weight reduction has been reported to lower VIIc levels [19].”
BackgroundTherapeutic interventions to lower plasma fibrinogen concentration
Ernst, E., & Resch, K. L. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_a.47 · Cited by 52 · see citing works
- Authors
- FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M.
- Affiliations
- University of Minnesota (US)
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- Corresponding author
- FOLSOM, A
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 91
- Issue
- 3
- Pages
- 191-205
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2001322531
- Cited by
- 321
- References
- 52
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 6
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC-55018, N01-HC55016, N01‐HC‐55015)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- fibrinogen, factor VII coagulant activity, cardiovascular risk factors, cardiovascular disease, Atherosclerosis Risk in Communities Study, sex differences, racial differences, modifiable lifestyle factors, smoking, alcohol consumption, physical activity, diabetes mellitus, insulin, lipoprotein(a), LDL cholesterol, HDL cholesterol, triglycerides, menopause, white blood cell count, aging
- MeSH terms
- Body Constitution, Cardiovascular Diseases, Coronary Disease, Factor VII, Female, Fibrinogen, Humans, Life Style, Lipids, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Factors, Smoking, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review